Congress of Clinical Rheumatology April 30
Transcription
Congress of Clinical Rheumatology April 30
Up to 28 hours AMA PRA Category 1 CreditsTM available. Congress of Clinical Rheumatology April 30-May 3, 2015 Sandestin hilton and conference center • Destin FL. dear colleagues, It is with pleasure that I invite you to attend the 31st Congress of Clinical Rheumatology being held Thursday, April 30 - Sunday, May 3, 2015 at the Sandestin Hilton Hotel and Resort in Destin, Florida, on Florida’s Emerald Coast. The Congress of Clinical Rheumatology is designed with the clinical rheumatologist in mind. Presentations include cutting edge topics, clinical guidelines, and evidence based medicine along with unique case studies. The faculty changes each year and is chosen according to the desired area of expertise and presenter’s skills. CCR 2015 is very fortunate to have faculty from universities throughout the world, including four from Europe. In addition, the faculty will contain four former CCR Outstanding Speaker Award winners—Iain McInnes, Ed Keystone, Susan Manzi, and Michelle Petri. Being an Outstanding Speaker is not an easy feat in a Rheumatology Who’s Who faculty. Other topics to be discussed will be CTD-associated ILD and sarcoid by Kristin Highland, M.D., who is boarded in Rheumatology and Pulmonary; an ICD-10 update by Charles King, II, MD, has just joined ACR’s Board Of Directors but was formerly the chairman of CORC for many years and; a Saturday Banquet with CCR and associated programs, but where there is only one meeting talk describing The Discovery of Cortisone by Thom Rooke, MD, a Mayo room, one fee to attend all the sessions, and one agenda. It is easy to see Professor, who authored, The Quest for Cortisone. Other faculty members will why many participants say they learn more at CCR than at any other meeting discuss often-overlooked topics, such as osteoporosis and chronic pain, as well they attend during the year. This is the perfect place to have a great time as new and emerging issues on the horizon. Jarred Younger, PhD, formerly of renewing old friendships, to meet the new fellows coming in for NYRIF the the Stanford Pain Center and currently at UAB, will discuss the importance of day before CCR, and to learn clinical rheumatology. Come and enjoy! microglial modulation in the development of more targeted treatment strategies in fibromyalgia whereas Iain McInnes will discuss the future prospects for RA and PsA treatments. All in all, it should be another outstanding meeting. CCR is the place to go to an international meeting with a world-class faculty, where participants can earn as many as 28 AMA PRA Category 1 Credits™ Best, David David McLain, MD, FACP, FACR; Symposium Director, CCR; Birmingham, AL. re g i ste r o n l i n e n o w at w w w . c c r h e um ato lo gy . c om FACULTY John Bilezikian, M.D. Daniel Doleys, Ph.D. Professor of Medicine and Pharmacology Chief, Division of Endocrinology Associate Chair (Education), Department of Medicine Columbia University College of Physicians and Surgeons New York, NY Director, The Doleys Clinic Author, Pain: Dynamics and Complexities Birmingham, AL Frank Buttgereit, M.D. Professor of Rheumatology Deputy Chief of the Department of Rheumatology and Clinical Immunology Charité - University Medicine Berlin, Germany Kristin Highland, M.D. Department of Pulmonary, Allergy & Critical Care Medicine, Respiratory Institute (Board Certified in Rheumatology and Pulmonary Disease) Cleveland Clinic Cleveland, OH 3 Laura Coates, M.D., PhD NIHR Clinical Lecturer University of Leeds Chapel Allerton Hospital Leeds, UK Edward Keystone, M.D. Professor of Medicine, University of Toronto Director, The Rebecca MacDonald Centre for Arthritis & Autoimmune Disease Director, The Division of Advanced Therapeutics in Arthritis Mount Sinai Hospital Joseph & Wolf Lebovic Health Complex Toronto, Ontario John J. Cush, M.D. Director of Clinical Rheumatology, Baylor Research Inst Professor of Medicine & Rheumatology, Baylor University Medical Center Clinical Professor of Internal Medicine, The University of Texas Southwestern Medical School Dallas, Texas Charles King, II, M.D. North Mississippi Health Services, Tupelo, MS FACULTY 4 Susan Manzi, M.D., MPH Chair, Department of Medicine, Allegheny Health Network Vice Chair and Professor Medicine Temple University School of Medicine Pittsburgh, PA Lisa Sammaritano, M.D. Associate Attending Physician, Hospital for Special Surgery Associate Professor of Clinical Medicine, Weill Cornell Medical College New York, NY Joseph Markenson, M.D. Attending Physician, Hospital for Special Surgery Professor of Clinical Medicine, Weill Cornell Medical College Attending Physician, Department of Medicine, Memorial Sloan-Kettering Cancer Center New York, NY Philip Seo, M.D., M.H.S. Assistant Professor of Medicine Director, Fellowship Program Division of Rheumatology Johns Hopkins University School of Medicine Director, The Johns Hopkins Vasculitis Center Baltimore, MD Iain McInnes, M.D., PhD, FRCP, FRSE, FMedSci Professor of Experimental Medicine Muirhead Professor of Medicine Director Institute of Infection, Immunity and Inflammation University of Glasgow Glasgow, Scotland, UK Athanasios G. Tzioufas, M.D. Director, Department of Pathophysiology School of Medicine University of Athens Athens, Greece Thom W. Rooke, M.D. John and Posy Krehbiel Professor of Medicine Mayo Medical School Rochester, MN Author, The Quest for Cortisone Jarred Younger, Ph.D. Associate Professor, Department of Psychology, Departments of Anesthesiology & Rheumatology Dir of the Neuroinflammation, Pain and Fatigue Lab at UAB University of Alabama at Birmingham Birmingham, AL THURSDAY, APRIL 30 7:00 AM Continental Breakfast, Exhibits 7:50 AM Welcome and Announcements David A. McLain, M.D. 8:00 AM Current and Emerging Treatments of Rheumatoid Arthritis Edward Keystone, M.D. 9:00 AM Pathogenesis and treatment of Rheumatoid Arthritis in 2020?3 Iain McInnes, M.D., PhD 10:00 AM Break 10:15 AM Treating to Target in Psoriatic Arthritis Laura Coates, M.D. 11:15 AM Reducing the Cost of Biologics: Dose Reduction, Withdrawal & Biosimilars Edward Keystone, M.D. 12:15 PM Lunch, Exhibits 1:15 PM PsA – a new future opening up? Iain McInnes, M.D., PhD 2:15 PM Update on ANCA-associated Vasculitis Philip Seo, M.D., M.H.S. 3:15 PM Break 3:30 PM CTD associated Interstital Lung Disease Kristin Highland, M.D. 4:25 PM Gout Update, a separate CME activity Joseph Grisanti, M.D. 5:25 PM Adjourn SUNDAY, MAY 3 6:15 AM Breakfast Workshop with Open Breakfast Buffet with Omelet Station 7:15 AM Adverse Drug Reactions and issues with newer therapies in RA - John J. Cush, M.D. 8:15 AM Non-malignant Chronic Pain Management Dan Doleys, Ph.D. agenda FRIDAY, MAY 1 6:30 AM Continental Breakfast, Exhibits 7:30 AM Clinical Update on Sarcoidosis Kristin Highland, M.D. 8:30 AM Glucocorticoids in Rheumatology: Clinical use, mechanisms of action Frank Buttgereit, M.D. 9:30 AM Break 9:45 AM Sjogren’s Syndrome: Clinical Presentation and Outcome Athanasios G. Tzioufas, M.D. 10:45 AM Glucocorticoids in Rheumatology: Adverse effects and new developments Frank Buttgereit, M.D. 11:45 PM Update on Therapies in SLE including Complimentary & Alternative Medications Susan Manzi, M.D., M.P.H. 12:45 PM Lunch, Exhibits 1:45 PM Lupus Pregnancy: Management and Outcome Lisa Sammaritano, M.D. 2:45 PM Sjogren’s Syndrome: Therapeutic modalities: Current status and future prospects Athanasios G. Tzioufas, M.D. 3:45 PM Break 4:00 PM CCR Thieves’ Market Alan Epstein, M.D 5:00 PM Adjourn 9:15 AM Break 9:30 AM Preventing Infections in patients on Biologics John J. Cush, M.D. 10:30 AM ICD-10 for Rheumatologists Charles King, II, M.D. 11:30 AM Congress Adjourns for 2015 SEE YOU NEXT YEAR SATURDAY, MAY 2 6:30 AM Continental Breakfast 7:30 AM Spondyloarthropathy Update, a separate CME activity, Alan Epstein, M.D. 8:30 AM Microglial Modulation in the Treatment of Fibromyalgia Jarred Younger, PhD 9:30 AM Break 9:45 AM New and Emerging Therapies in Osteoporosis John Bilezikian, M.D. 10:45 AM Rheumatic Manifestations of Endocrine Disease Joseph Markenson, M.D. 11:45 AM The Year in Review: Osteoporosis John Bilezikian, M.D. 12:45 PM Lunch, Exhibits 1:45 PM Lupus Update, a separate CME activity Michelle Petri, M.D., M.P.H. 2:45 PM OA update, a separate CME activity John Tesser, M.D. 3:45 PM Adjourn 6:30 PM Cocktail Reception 7:00 PM Banquet 7:15 PM Welcome, prize drawings 7:30 PM CME Banquet Talk The Discovery of Cortisone Thom W. Rooke, M.D. 8:30 PM Adjourn 5 “The Spectrum of Gout and Hyperuricemia: Acute Attacks to Refractory Chronic Gout” Earn 1.0 AMA PRA Category 1 Credits™ s e pa r ate a ct i v i t y You are invited to participate in an educational program that was created to provide physicians, physician assistants, and rheumatology nurse practitioners with the knowledge base, skills set, and tools needed to incorporate the “The Spectrum of Gout and Hyperuricemia: Acute Attacks to Refractory Chronic Gout” CME educational activity into clinical practice. Upon completion of the program participants will be able to: 6 1Describe the pathophysiology of hyperuricemia and gout, and the mechanisms leading to an acute gout attack 2Describe advances in the understanding of the epidemiology of hyperuricemia and gout, and the relationship between hyperuricemia, risk factors, and comorbidities 3Evaluate and select among the current and innovative treatments of hyperuricemia and gout, utilizing current data on efficacy and safety 4Use currently accepted standards of care to manage patients with hyperuricemia and gout, including: • When managing acute attacks • When implementing prophylaxis • When treating chronic hyperuricemia • When managing gout resistant to first line treatments Joseph M. Grisanti, M.D., FACP, FACR. Medical Director, Buffalo Rheumatology Chief of Rheumatology, Mercy Hospital of Buffalo Assistant Clinical Professor of Medicine, SUNY Buffalo Orchard Park, NY Accreditation and Educational Credit This educational activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University Health Services Professional Education Programs, Inc. (UHS-PEP) of Virginia Commonwealth University Health System and Miller Professional Group. UHS-PEP is accredited by the ACCME to provide continuing medical education for physicians. UHS-PEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This continuing education activity meets the criteria of VCU and the Southern Association of Colleges and Schools. For each activity 0.1 CEUs will be awarded and recorded with the University. This program is supported by an educational grant from Crealta Pharmaceuticals, Inc. “Diagnosis and Management of the Spondyloarthropathies (SpA)-Impact of Treat to Target Guidelines” Earn 1.0 AMA PRA Category 1 Credits™ s e pa r ate a ct i v i t y You are invited to participate in an educational program that was created to provide participants with the knowledge base, skills set, and tools needed to incorporate the “Diagnosis and Management of the Spondyloarthropathies (SpA)-Impact of Treat to Target Guidelines” CME educational activity into clinical practice. Upon completion of the program participants will be able to: 1Identify patients with chronic low back pain who are at risk for SpA. 2Use current ASAS diagnostic criteria to make a correct definite diagnosis of SpA. 3Explain the rationale of the current SpA management recommendations. 4Implement the appropriate management of their patients accordingly. 5Evaluate strategies for educating patients about SpA and life with the disease. 6Apply these strategies in their clinical practices as applicable to the patient pool, and improve how they involve patients in the therapeutic decision making process. Alan Epstein, MD, FACP, FACR. Associate Professor of Medicine, University of Pennsylvania School of Medicine Philadelphia, PA Accreditation and Educational Credit This educational activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University Health Services Professional Education Programs, Inc. (UHS-PEP) of Virginia Commonwealth University Health System and Miller Professional Group. UHS-PEP is accredited by the ACCME to provide continuing medical education for physicians. UHS-PEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This continuing education activity meets the criteria of VCU and the Southern Association of Colleges and Schools. For each activity 0.1 CEUs will be awarded and recorded with the University. This program is supported by educational grants from AbbVie, Inc., Amgen, Inc., Janssen Biotech, Inc, and UCB, Inc. ““Evaluation and Management of Systemic Lupus Erythematosus, 2015” Earn 1.0 AMA PRA Category 1 Credits™ s e pa r ate a ct i v i t y You are invited to participate in an educational program that was created to provide participants with the knowledge base, skills set, and tools needed to incorporate the “Evaluation and Management of Systemic Lupus Erythematosus, 2015” CME educational activity into clinical practice. Upon completion of the program participants will be able to: 1Evaluate the importance of the disease burden in SLE, consequences of inadequate disease control, and consequences of inflammatory burden on patients, their families, their communities and the healthcare system. 2Describe and discuss the impact of disease activity on patient outcomes, and the challenges of implementing treat to target concepts as applicable in the management of this highly pleomorphic disease. 3Apply current concepts of management including approaches to measurement of organ inflammation and/or involvement and disease activity. 4Collaborate with patients in the implementation of treatment goals. 5Apply the principles of evidence based medicine to optimize SLE patient care. a) Effectively use currently available tools for assessing disease activity in patients with lupus;Evaluate the EULAR monitoring guidelines and apply them into the care of their lupus patients. b) Apply the treatment strategies from the EULAR and ACR guidelines and SLICC in their clinicalpractices and thereby optimize patient care and functioning. Michelle Petri, MD, MPH Professor of Medicine, Johns Hopkins University School of Medicine Director, Hopkins Lupus Center Baltimore, MD Accreditation and Educational Credit This educational activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University Health Services Professional Education Programs, Inc. (UHS-PEP) of Virginia Commonwealth University Health System and Miller Professional Group. UHS-PEP is accredited by the ACCME to provide continuing medical education for physicians. UHS-PEP designates this live program for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This continuing education activity meets the criteria of VCU and the Southern Association of Colleges and Schools. For each activity 0.1 CEUs will be awarded and recorded with the University. This program is supported by an educational grant from UCB. “Utilization of Viscosupplementation in the Treatment of Knee Osteoarthritis: Identifying Potential Patients” Earn 1.0 AMA PRA Category 1 Credits™ s e pa r ate a ct i v i t y You are invited to participate in an educational program that was created to provide participants with the knowledge base, skills set, and tools needed to incorporate the “Utilization of Viscosupplementation in the Treatment of Knee Osteoarthritis: Identifying Potential Patients” CME educational activity into clinical practice. Upon completion of the program participants will be able to: 1Describe the demographics, impact, etiology and pathophysiology of osteoarthritis of the knee. 2Implement current guidelines for diagnosis and evaluation of the patient with osteoarthritis of the knee, including consideration of comorbidities impacting treatment decisions. 3Utilize appropriately currently available treatment modalities including oral and local therapeutic options, and non-pharmacologic options. 4Recognize patients who have clinical characteristics indicatingappropriate utilization of hyaluronan therapy. John RP Tesser, MD, FACP, FACR Clinical Lecturer in Internal Medicine, University of Arizona Health Sciences Center Midwestern University, Arizona College of Osteopathic Medicine, Phoenix, Arizona Accreditation and Educational Credit This This educational activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University Health Services Professional Education Programs, Inc. (UHS-PEP) of Virginia Commonwealth University Health System and Miller Professional Group. UHS-PEP is accredited by the ACCME to provide continuing medical education for physicians. UHS-PEP designates this live program for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This continuing education activity meets the criteria of VCU and the Southern Association of Colleges and Schools. For each activity 0.1 CEUs will be awarded and recorded with the University. This program is supported by an educational grant from Fidia Inc. 7 Traveling To Destin Direct flights are now available on Southwest (to Northwest Florida Beaches International Airport at Panama City [Airport code: ECP]) from BWI, Houston, Nashville, St Louis and direct flights on Delta from Atlanta. The closest airport is Northwest Florida Regional Airport (VPS) at Fort Walton Beach. Direct flights are available on American from Dallas, on Continental from Houston, on Delta from Atlanta, and on US Airways from Charlotte. Accommodations Hilton Hotel, Destin, Florida where the meeting is held. Room rate—Single or Double: $249.00 per night plus applicable taxes and fees. Book your room directly with the Hilton Hotel. Call the Hilton directly at (850) 267-9500 or toll-free at 1-800367-1271 and speak with a hotel representative or visit http:// www.sandestinbeachhilton.com. Our SPECIAL GROUP CODE to give the reservationist is CCR. 8 Any hotel reservation made after April 1, 2015 will be taken on a space available basis at the PREVAILING RATE. LAST YEAR OUR ROOM BLOCK WAS FILLED BEFORE THE CUT-OFF DATE! Hilton Sandestin Golf Resort & Spa 2014 Certificate of Excellence, TripAdvisor 2014 Best Hotels in the USA, U.S. News & World Report 2014 Top 100 Resorts, Event Supplier Network Meeting Planners In order to receive the CCR room rate, you must be registered for the Congress of Clinical Rheumatology. Other hotel accommodations are available next to the Hilton with meeting rates available. Rooms from $169! For more information see: http://www.ccrheumatology.com and click Accommodations [www.ccrheumatology.com/places-to-stay]. ccr thieves’ market On Friday, May 1 , CCR will host a st Thieves’ Market moderated by Dr. Accreditation & credit statement Goals & Objectives At the conclusion of this forum, the attendees should be able to: Alan Epstein, M.D. of the University of This educational activity has been 1. Identify, evaluate and manage 9. Utilize recent updates to treat pain Pennsylvania. planned and implemented in accordance patients with rheumatologic and with fibromyalgia. Cases are being solicited from all with the accreditation requirements and immunologic diseases according to the 10. Summarize current concepts of attendees of CCR. Submissions are policies of the Accreditation Council for most up-to-date guidelines and clinical chronic pain management. due by April 1st, 2015. Cases are to Continuing Medical Education (ACCME) developments. 11. Determine the best strategy to be presented as “stumpers” in the through the joint providership of University 2. Outline the new developments in “Treat to Target” for patients with Thieves’ Market style. Each presenter Health Services Professional Education the diagnosis and treatment of ANCA- psoriatic arthritis. is provided up to 10 minutes including Programs, Inc. (UHS-PEP) of Virginia associated vasculitis. 12. Recognize and diagnose unusual discussion. If you would like to present Commonwealth University Health System 3. Evaluate and employ the most presentations of uncommon as well as a case, email Alan Epstein at thieves@ and A&R Educational Group, LLC. UHS- recent updates in the pathogenesis common rheumatologic diseases, as ccrheumatology.com. PEP is accredited by the ACCME to and treatment of rheumatoid arthritis, presented at the Thieves’ Market Include: provide continuing medical education for psoriatic arthritis, and sarcoidosis for 13. Evaluate the ICD-10 coding 1 Your Name physicians. best outcomes. changes that are upcoming for 2 Mailing Address UHS-PEP designates this live program for 4. Explain how to successfully manage rheumatologists. pregnancy in lupus. 14. Recognize rheumatic manifestations 5. Select the best single or combination of endocrine diseases. 3 Daytime Phone Number a maximum of 24 AMA PRA Category 1 4 Evening Phone Number Credits™. Physicians should claim only 5 E-mail Address the credit commensurate with the extent of of therapeutic agents to individually 15. Explain the effects of and the new 6 Brief paragraph describing your their participation in the activity manage osteoporosis therapy and development with corticosteroids and proposed presentation and title. This continuing education activity meets evaluate the current development of their discovery, the associated adverse 7 Presentation in Power Point format the criteria of VCU and the Southern new agents and strategies in treatment. events, and the new developments. There will be an award for the top case Association of Colleges and Schools. For 6. Compare and contrast the current 16. Explain the adverse effects of selected and presented. each activity 2.4 CEUs will be awarded and and recently approved therapeutic agents utilized for rheumatoid arthritis See www.ccrheumatology.com/thieves recorded with the University. agents available for the treatment of and strategies to prevent infections pulmonary fibrosis associated with associated with these agents. for complete entry criteria. Become a Part of the 2015 Program. You must be a registered attendee at CCR to present at the Thieves’ Market. connective tissue diseases. 7. Evaluate Sjogren syndrome patients for multi-system involvement and devise Alan Epstein, M.D. Associate Professor of Medicine University of Pennsylvania School of Medicine a plan to manage their potential needs. 8. Evaluate and discuss the current information on traditional, complementary and alternative medications available for systemic lupus erythematosus. 9 NYRIF 10 North American Young Rheumatology Investigator Forum The 9th Annual North American Young Rheumatology Investigator Forum will be held Wednesday April 29, 2015 at the Hilton Sandestin in Destin, Florida in conjunction with the 31st Annual Congress of Clinical Rheumatology. NYRIF’s unique format fosters mentorship and emphasizes interaction between the registrants and faculty and provides an excellent platform for clinical and research oriented rheumatology fellows and junior faculty to have their clinical and basic research efforts reviewed, critiqued and evaluated by an acclaimed geographically diverse panel of rheumatologists. The top abstracts will be presented as either an oral or poster presentation to an international audience. In the afternoon, a roundtable discussion with rheumatologists established in the paths of research, clinical practice and the pharmaceutical industry will explore career opportunities, challenges, and lifestyles in the various fields of rheumatology to assist fellows with their upcoming career decisions. Travel stipends of $250-$1000 will be awarded to those candidates whose efforts have been considered by the faculty to have exceptional promise. NYRIF is designed to be stimulating, interactive and constructive whereby attendees are able to exchange ideas in an informal, mentoring environment and develop invaluable networks with the faculty and peers to facilitate future career contacts. All fellows and junior staff from the U.S. and Canada within the field of rheumatology are welcome to attend NYRIF and are invited to stay for the 31st Annual Congress of Clinical Rheumatology that will immediately follow NYRIF. The CCR registration fee will be waived for all accepted abstract registrants. Faculty Judging Panel The esteemed international judging panel this year includes Dr. Frank Buttergereit, Charité-University Medicine Berlin, Germany; Dr. Laura Coates, University of Leeds, England; Susan Manzi, Temple University and Philip Seo of Johns Hopkins. Dr. Iain McInnes, University of Glasgow, Scotland will again will be presiding as the lead judge and moderator. Submission Guidelines Rheumatology fellows and junior faculty from the U.S. and Canada are invited to submit abstracts of their original basic or clinical research findings. The ten most exceptional abstracts will be chosen by the judging panel for oral presentations and receive a travel stipend of $1000 each. The next fifteen deemed to be highly meritorious will be asked to present in a poster session and will receive $500 for travel and meeting expenses. Five remaining abstracts will be chosen to receive a travel/meeting stipend of $250. Notification of abstract acceptance for oral or poster presentation as well as category of travel stipend award will be made by email by April 12, 2015. All judges’ decisions are final. Abstract submission deadline is March 25, 2015. For further information on NYRIF, full submission guidelines, or to submit an abstract, please visit: http://www.nyrif.com Accreditation This activity has been approved for AMA PRA Category 1 CreditsTM. Accommodations The Hilton Sandestin is offering a limited number of rooms April 28 - 30, 2015 for fellows attending NYRIF at special discounted rate of $199/night. For further questions, please contact [email protected]. Call for Abstracts! registration form re g i ste r o n l i n e n o w at w w w . c c r h e um ato lo gy . c om Mail or Fax form to Congress of Clinical Rheumatology FAX#: (205) 991-9911 A&R Educational Group, LLC, 6225 Cahaba Valley Road, Birmingham, AL 35242 Name Specialty Phone NPI Address City State Zip Code Email Address Payment Method □ Credit Card □ Check □ Money Order Credit Card □ VISA □ Mastercard □ American Express Name on Card Card Number Card Billing Zip Code CVV □ Discover Expiration Date Total From Below 11 Signiture Registration Fees CCR Physician Registration Fee CCR Physician Day Registration Specify Day(s)_______________ CCR AHP Registration Fee CCR AHP Day Registration Specify Day(s)_______________ Retired Physician Physician In Training: This registration is for Residents and Fellows ONLY. A written letter from your Program Director is required.* Banquet Saturday Night (Circle One: Surf and Turf/Vegetarian, max 2 per registrant, 1 hr of CME, Must be registered to Attend) Banquet Saturday Night Spouse/Guest (Circle One: Surf and Turf/Vegetarian) Before 4/12/15 $450 $185/day On/After 4/12/15 $525 $185/day $400 $150/day $475 $150/day $250 $200* $300 $225 □ Attending included in registration fee □ Attending included in registration fee Total Fees (include in total above) “Truly the best clinical rheum meeting of the year.” Allan Morton, D.O., Detroit, MI □ Not Attending □ Not Attending There will be a $25 surcharge for registrations received on site. Refund policy: An administrative fee of $50 will be charged prior to 4/10/15 and $100 thereafter; no refunds will be issued after April 29, 2015. Cancellation Policy: A&R Educational Group, LLC reserves the right to cancel this conference due to insufficient enrollment or unforeseen circumstances. * Registration fee waived if attending NYRIF with abstract submitted. NYRIF National Young Rheumatology Investigator Forum Dr. Iain McInnes will chair the sessions with other panel members Drs. Frank Buttgereit, Laura Coates, Susan Manzi, and Phillip Seo . Submit abstracts at: http://nyrif.com Congress of Clinical Rheumatology• April 30- may 3, 2015 Sandestin hilton and conference center • Destin FL. re g i ste r o n l i n e n o w at w w w . c c r h e um ato lo gy . c om